Table 1.
Trial | Still on drug at end of follow-up (censored) | Reason for withdrawal | |||||
Adverse events | Seizure control | Remission | Seizure control and adverse events | Unclear | Total number of patients in trial | ||
Heller et al., 199518 | 131 | 25 | 29 | 36 | 15 | 7 | 243 |
De Silva et al., 199619 | 41 | 9 | 35 | 59 | 19 | 4 | 167 |
Mattson et al., 198520 | 312 | 25 | 16 | 0 | 108 | 14 | 475 |
Mattson et al., 199221 | 291 | 68 | 50 | 0 | 0 | 71 | 480 |
Richens et al., 199422 | 196 | 37 | 34 | 0 | 2 | 23 | 292 |
Verity et al., 199523 | 175 | 23 | 30 | 0 | 11 | 7 | 246 |
Brodie et al., 1995a24 | 85 | 40 | 3 | 0 | 2 | 6 | 136 |
Brodie et al., 1995b24 | 90 | 28 | 4 | 0 | 0 | 2 | 124 |
Ramsay et al., 199225 | 112 | 10 | 3 | 0 | 0 | 11 | 136 |
Turnbull et al., 198526 | 97 | 5 | 20 | 0 | 0 | 18 | 140 |
Placencia et al., 199327 | 159 | 10 | 0 | 0 | 0 | 23 | 192 |
Brodie et al., 199928 | 106 | 40 | 2 | 0 | 2 | 0 | 150 |
Bill et al., 199729 | 239 | 22 | 2 | 0 | 0 | 24 | 287 |
Guerreiro et al., 199730 | 158 | 16 | 7 | 0 | 1 | 11 | 193 |
Nieto-Barrera et al., 200131 | 534 | 70 | 18 | 0 | 0 | 0 | 622 |